Koo, Tin-Yan
Lai, Hinyuk
Nomura, Daniel K. http://orcid.org/0000-0003-1614-8360
Chung, Clive Yik-Sham http://orcid.org/0000-0003-1382-719X
Funding for this research was provided by:
Research Grants Council, University Grants Committee (Early Career Scheme (27315922), Theme-based Research Scheme (T12-716/22-R))
Article History
Received: 30 October 2022
Accepted: 2 June 2023
First Online: 15 June 2023
Competing interests
: A patent application from C.Y.-S.C., H.L., and T.-Y.K. has been filed for NAIA, and the US patent application number is 18/307,905. D.K.N. is a co-founder, shareholder, and scientific advisory board member for Frontier Medicines and Vicinitas Therapeutics. D.K.N. is a member of the board of directors for Vicinitas Therapeutics. D.K.N. is on the scientific advisory board of The Mark Foundation for Cancer Research, MD Anderson Cancer Center, Photys Therapeutics, Apertor Pharmaceuticals, Oerth Bio, and Chordia Therapeutics. D.K.N. is also an Investment Advisory Board Member for Droia Ventures and a16z.